47
Auron Therapeutics, Inc. raises $7.1M under Reg D
Company raise · Raising · Offering $12M · Sold $7.1M · WELLESLEY, MA · filed 2026-08-13
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Anna Duncan French | Director |
| Alon Duncan Lazarus | Director |
| Serge Duncan Messerlian | Director |
| Katharine Yen | Executive Officer, Director |
| Alexandra Cantley | Director |
| Victoria Duncan Richon | Director |
| Briggs Duncan Morrison | Director |
Signed by Katharine Yen, Chief Executive Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.